# Feasibility of the LUM Imaging System for Detection of Cancer to the Brain

> **NCT03717142** · NA · TERMINATED · sponsor: **Lumicell, Inc.** · enrollment: 4 (actual)

## Conditions studied

- Low Grade Glioma of Brain
- Glioblastoma
- Metastasis to Brain

## Interventions

- **COMBINATION_PRODUCT:** LUM Imaging System

## Key facts

- **NCT ID:** NCT03717142
- **Lead sponsor:** Lumicell, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-05-03
- **Primary completion:** 2023-09-13
- **Final completion:** 2024-06-14
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Initial data indicated a change in study design required prior to collecting additional data.
- **Last updated:** 2025-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03717142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03717142, "Feasibility of the LUM Imaging System for Detection of Cancer to the Brain". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT03717142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*